Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EDAP TMS S.A. (EDAP), a developer and marketer of Ablatherm, has signed distribution agreements with partners in Argentina, Brazil and Chile to drive adoption of Ablatherm in the region as a therapeutic option for patients with prostate cancer. The company's partners will include Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile.
Subscribe to our email newsletter
Marc Oczachowski, EDAP’s chief executive officer, stated that the company strongly believes Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile are the right partners to develop and build our presence in these countries as part of an ongoing effort to drive geographic expansion of our minimally-invasive HIFU option to patients with localized prostate cancer. Several clinical institutions have been showing strong interest in offering Ablatherm-HIFU to their patients and we are very enthusiastic to now provide them with a solution.